We are live on ! Find out more
BCM

Brookmont Capital Management Portfolio holdings

AUM $186M
1-Year Est. Return 10.11%
This Fund
S&P 500
This Quarter Est. Return
+4.65%
1 Year Est. Return
+10.11%
3 Year Est. Return
+36.63%
5 Year Est. Return
+48.26%
10 Year Est. Return
+211.29%
AUM
$270M
AUM Growth
+$16.6M
Cap. Flow
+$5.68M
Cap. Flow %
2.1%
Top 10 Hldgs %
45.2%
Holding
54
New
4
Increased
12
Reduced
36
Closed
–

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$2.68M
2
AMGN icon
Amgen
AMGN
+$2.39M
3
PKG icon
Packaging Corp of America
PKG
+$1.97M
4
HUBB icon
Hubbell
HUBB
+$1.64M
5
MSFT icon
Microsoft
MSFT
+$510K

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$730K
2
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$502K
3
PG icon
Procter & Gamble
PG
+$419K
4
MCHP icon
Microchip Technology
MCHP
+$370K
5
HON icon
Honeywell
HON
+$292K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.52%
2 Healthcare 13.85%
3 Financials 13.75%
4 Energy 12.85%
5 Technology 11.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
26
Amgen
AMGN
$207B
$3.58M 1.32%
21,834
+14,382
+193% +$2.39M
LYB icon
27
LyondellBasell Industries
LYB
$19.9B
$3.54M 1.31%
38,800
-89
-0.2% -$8.12K
NVO
28
Novo Nordisk
NVO
$208B
$3.51M 1.3%
204,526
+23,640
+13% +$412K
SON icon
29
Sonoco
SON
$5.55B
$3.41M 1.26%
64,506
-754
-1% -$40.6K
VZ icon
30
Verizon
VZ
$194B
$2.89M 1.07%
59,316
+397
+0.7% +$19.9K
SO icon
31
Southern Company
SO
$109B
$2.83M 1.05%
56,930
-151
-0.3% -$7.46K
GILD icon
32
Gilead Sciences
GILD
$162B
$2.59M 0.96%
+38,081
New +$2.68M
PKG icon
33
Packaging Corp of America
PKG
$21.9B
$1.97M 0.73%
+21,477
New +$1.97M
HUBB icon
34
Hubbell
HUBB
$25.2B
$1.64M 0.61%
+13,692
New +$1.64M
RTN
35
DELISTED
Raytheon Company
RTN
$1.58M 0.58%
10,369
-48
-0.5% -$7.22K
ACN icon
36
Accenture
ACN
$101B
$1.41M 0.52%
11,766
-73
-0.6% -$8.72K
HON icon
37
Honeywell
HON
$77.3B
$1.2M 0.44%
10,658
-2,644
-20% -$292K
SBUX icon
38
Starbucks
SBUX
$120B
$1.07M 0.4%
18,336
-152
-0.8% -$8.6K
XOM icon
39
ExxonMobil
XOM
$639B
$797K 0.29%
9,722
-116
-1% -$9.69K
CVS icon
40
CVS Health
CVS
$134B
$772K 0.29%
9,830
-48
-0.5% -$3.83K
SYK icon
41
Stryker
SYK
$125B
$727K 0.27%
5,526
-96
-2% -$12.1K
UNP icon
42
Union Pacific
UNP
$174B
$620K 0.23%
5,856
-80
-1% -$8.53K
IVV icon
43
iShares Core S&P 500 ETF
IVV
$876B
$586K 0.22%
2,469
+71
+3% +$16.6K
EFA icon
44
iShares MSCI EAFE ETF
EFA
$78B
$578K 0.21%
9,279
+294
+3% +$17.8K
LHX icon
45
L3Harris
LHX
$51.7B
$567K 0.21%
5,095
-118
-2% -$12.6K
SRE icon
46
Sempra
SRE
$58.3B
$560K 0.21%
10,144
-96
-0.9% -$5.1K
AGG icon
47
iShares Core US Aggregate Bond ETF
AGG
$137B
$546K 0.2%
5,037
+95
+2% +$10.3K
MSFT icon
48
Microsoft
MSFT
$3.43T
$525K 0.19%
+7,964
New +$510K
IJR icon
49
iShares Core S&P Small-Cap ETF
IJR
$110B
$482K 0.18%
6,968
-7,276
-51% -$502K
IJH icon
50
iShares Core S&P Mid-Cap ETF
IJH
$122B
$478K 0.18%
13,965
-160
-1% -$5.45K
1
2
3

Similar funds

SEP
Signature Equity Partners Columbus, Ohio $186M AUM
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
BGA
Battery Global Advisors Boston, Massachusetts $186M AUM 15.74% 1-Year Est. Return
OBC
Oakum Bay Capital Westport, Connecticut $187M AUM
LPCM
Lynwood Price Capital Management Austin, Texas $186M AUM 5.63% 1-Year Est. Return
HC
Hurley Capital New York $187M AUM 23.24% 1-Year Est. Return
AC
AMANSA Capital Raffles City Tower, Singapore $187M AUM 38.38% 1-Year Est. Return
WWM
Whalen Wealth Management Las Vegas, Nevada $187M AUM 18.9% 1-Year Est. Return

Brookmont Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Brookmont Capital Management held 54 positions worth $270M, up 6.5% from $254M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Brookmont Capital Management's Q1 2017 filing shows 4 new, 12 increased and 36 reduced positions. Its largest new stake was Gilead Sciences: 38,081 shares worth $2.59M. The largest sale was Abbott, an estimated $730K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Brookmont Capital Management's largest Q1 2017 buy was Gilead Sciences: 38,081 shares worth $2.59M.
  • Brookmont Capital Management added most to Amgen in Q1 2017, an estimated $2.39M increase.
  • Brookmont Capital Management's biggest Q1 2017 reduction was Abbott, cutting an estimated $730K.
  • Brookmont Capital Management's ten largest holdings make up 45% of its $270M portfolio in Q1 2017.
  • Brookmont Capital Management opened 4 new positions and closed 0 in Q1 2017.
  • Brookmont Capital Management's portfolio value rose 6.5% quarter-over-quarter to $270M.

Based on Brookmont Capital Management's 13F filing for Q1 2017, filed 15 May 2017.